1. Home
  2. AVLN vs ALX Comparison

AVLN vs ALX Comparison

Compare AVLN & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$28.73

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Alexander's Inc.

ALX

Alexander's Inc.

N/A

Current Price

$258.70

Market Cap

1.3B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
AVLN
ALX
Founded
N/A
1928
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2026
1994

Fundamental Metrics

Financial Performance
Metric
AVLN
ALX
Price
$28.73
$258.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
258.9K
14.8K
Earning Date
N/A
05-04-2026
Dividend Yield
N/A
7.20%
EPS Growth
N/A
N/A
EPS
N/A
0.91
Revenue
N/A
$213,183,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$290.35
Revenue Growth
N/A
N/A
52 Week Low
$24.90
$201.28
52 Week High
$33.32
$289.43

Technical Indicators

Market Signals
Indicator
AVLN
ALX
Relative Strength Index (RSI) 43.91 37.03
Support Level $26.68 $251.85
Resistance Level $29.59 $271.02
Average True Range (ATR) 1.99 6.52
MACD 0.19 -2.77
Stochastic Oscillator 61.44 5.57

Price Performance

Historical Comparison
AVLN
ALX

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About ALX Alexander's Inc.

Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing, and redeveloping its properties. It has five properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City, which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.

Share on Social Networks: